K. K. Pharma Solutions

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Delivery Time: within a week

Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses.2 It was generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice.2 It is a targeted biologic disease-modifying anti-rheumatic drug (bDMARDs) that is used in the management of various inflammatory conditions that involve the activation of IL-12 and IL-23 signalling pathways.1

The therapeutic use of the drug started in Canada, the US, and Europe since 2009 when it was first approved for the treatment of adult patients with moderate to severe plaque psoriasis and active psoriatic arthritis, alone or in combination with methotrexate. In September 2016, ustekinumab was additionally approved for the management of moderate to severe Crohn's disease in selected adult patients. In October 2019, it was also approved by the FDA for use to manage moderately to severely active ulcerative colitis in adults. Ustekinumab is currently the first and only approved biologic therapy for ulcerative colitis that targets the interleukin (IL)-12 and IL-23 cytokines.7 The dosing regimen for ustekinumab is based on the patient's weight and there are intravenous and subcutaneous formulations of the drug based on the dosing schedule and condition being treated. Ustekinumab is commonly marketed under the trade name STELARA.

Ustekinumab biosimilars are available in some markets, including Wezlana (ustekinumab-auub) in the US11 and Jamteki (AVT04) in Canada.12

Factocel IX 600IU Injection  contains active components such as factor IX. In some cases, individuals with hemophilia A (caused by a deficiency of factor VIII) may develop inhibitors (antibodies) against factor VIII, making standard treatment less effective. In such situations, it may be considered as an alternative. It can be used before, during, and after surgery to prevent excessive bleeding. Some people with hemophilia B may receive it  as a preventive measure to maintain a certain level of this in their bloodstream, reducing the risk of spontaneous bleeding episodes, particularly in joints and muscles. It may be administered following traumatic injuries or accidents to prevent or control bleeding. In rare cases, it may be considered for treating other bleeding disorders or conditions that involve a deficiency, such as acquired hemophilia.

If a person has a known allergy or hypersensitivity to Factocel IX 600IU Injection or any components of  this product, it is a contraindication to its use.  It is inappropriate for individuals with DIC, a complex bleeding disorder characterized by abnormal clotting and bleeding. People with severe liver disease may not respond well to it, and the risks and benefits should be carefully weighed. While it is commonly used in pediatric patients with hemophilia B, the dosage and administration should be carefully adjusted based on age and weight, and the treatment should be closely monitored. Factocel IX 600IU Injection replacement therapy can be safe and effective for older adults with hemophilia B. However, dosing and treatment plans may need to be adjusted based on individual health and medical history.

Additional Information:

• Delivery Time: within week

• Cefoperazone: An antibiotic that prevents bacteria from forming a protective covering 
• Sulbactam: A beta-lactamase inhibitor that reduces resistance and enhances the activity of Cefoperazone against bacteria 

Before receiving MABALL 100MG INJECTION, inform your doctor if you are taking any of the following medicines such as:

• medicines used to manage high blood pressure (such as atenolol, propranolol, amlodipine, enalapril, olmesartan, losartan)
• medicines that can suppress immune functions (such as ciclosporin, tacrolimus)
• other anticancer medicines (such as Trastuzumab, Bevacizumab, Alemtuzumab, Cetuximab)

Neukine 300mcg injection contains filgrastim as its active ingredient. It is used in patients who are undergoing treatment with chemotherapy to prevent infections. It will be given to you in a hospit

al or clinic by a doctor or nurse as an injection. You should avoid self-injecting. Before starting this medicine, inform your doctor if you are pregnant, planning a pregnancy or are breastfeeding and about all the medicines and supplements you take and all the conditions or diseases you suffer from.

Cancidas 50mg Injection is administered as an injection by a healthcare professional. Kindly do not self-administer. Do not skip any doses and finish the full course of treatment even if you feel better. Your doctor may monitor your liver function regularly during treatment.

Cancidas 50mg Injection may lead to a few common side effects like rash, decreased potassium level in the blood, fever, increased liver enzymes, chills, and diarrhea. You may also notice some injection site reactions like pain, swelling, or redness. Inform your doctor if these side effects persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive, or breastfeeding.

Casfung 70mg Injection is administered as an injection by a healthcare professional. Kindly do not self-administer. Do not skip any doses and finish the full course of treatment even if you feel better. Your doctor may monitor your liver function regularly during treatment.

Casfung 70mg Injection may lead to a few common side effects like rash, decreased potassium level in the blood, fever, increased liver enzymes, chills, and diarrhea. You may also notice some injection site reactions like pain, swelling, or redness. Inform your doctor if these side effects persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive, or breastfeeding

Additional Information:

• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 month
• Delivery Time: within week

Menopur Injection is given as an injection under the supervision of a doctor. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed with certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include headache, injection site pain, injection site allergic reaction, abdominal swelling, or pain. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Male might notice acne, or sweating and deepening of the voice. 

Before taking this medicine, tell your doctor if you have ever had heart disease, or had an ovarian cyst, or had thyroid gland disorder. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant or breastfeeding. You should avoid alcohol or have to follow doctor advice related to diet while taking this medicine.

Additional Information:

• Production Capacity: 36 month
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week

Additional Information:

• Production Capacity: 36 months
• Delivery Time: within week